褐藻糖胶
结肠炎
失调
炎症性肠病
微生物学
肠道菌群
化学
微生态学
生物
生物化学
多糖
免疫学
医学
内科学
疾病
作者
Haitao Xiao,Jinxiu Feng,Jiao Peng,Peigen Wu,Yaoyao Chang,Xianqian Li,Jinhui Wu,Haifeng Huang,Huan Deng,Miao Qiu,Yuedong Yang,Bin Du
出处
期刊:Marine Drugs
[Multidisciplinary Digital Publishing Institute]
日期:2022-12-25
卷期号:21 (1): 16-16
被引量:7
摘要
The dysbiosis of intestinal microecology plays an important pathogenic role in the development of inflammatory bowel disease.A polysaccharide named Fuc-S, with a molecular weight of 156 kDa, was prepared by the ultrasonic degradation of fucoidan. Monosaccharide composition, FTIR, methylation, and NMR spectral analysis indicated that Fuc-S may have a backbone consisting of →3)-α-L-Fucp-(1→, →4)-α-L-Fucp-(1→ and →3, 4)-α-D-Glcp-(1→. Moreover, male C57BL/6 mice were fed three cycles of 1.8% dextran sulfate sodium (DSS) for 5 days and then water for 7 days to induce colitis. The longitudinal microbiome alterations were evaluated using 16S amplicon sequencing. In vivo assays showed that Fuc-S significantly improved clinical manifestations, colon shortening, colon injury, and colonic inflammatory cell infiltration associated with DSS-induced chronic colitis in mice. Further studies revealed that these beneficial effects were associated with the inhibition of Akt, p-38, ERK, and JNK phosphorylation in the colon tissues, regulating the structure and abundance of the gut microbiota, and modulating the host-microbe tryptophan metabolism of the mice with chronic colitis.Our data confirmed the presence of glucose in the backbone of fucoidan and provided useful information that Fuc-S can be applied as an effective functional food and pharmaceutical candidate for IBD treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI